These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26552838)

  • 1. High-throughput automated dissolution method applicable for a wide dose range of controlled release pellets.
    Petruševska M; Horvat M; Peternel L; Kristan K
    Drug Dev Ind Pharm; 2016; 42(7):1149-57. PubMed ID: 26552838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring dissolution profiles of single controlled-release drug pellets.
    Bhakta HC; Lin JM; Grover WH
    Sci Rep; 2020 Nov; 10(1):19734. PubMed ID: 33184351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.
    Jedinger N; Schrank S; Fischer JM; Breinhälter K; Khinast J; Roblegg E
    AAPS PharmSciTech; 2016 Feb; 17(1):68-77. PubMed ID: 26206403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state characterization, solid dispersions, solubility enhancement, drug dissolution and drug release.
    Alany R
    Pharm Dev Technol; 2017 Feb; 22(1):1. PubMed ID: 28117622
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a high-throughput screening method for the detection of the excipient-mediated precipitation inhibition of poorly soluble drugs.
    Petruševska M; Urleb U; Peternel L
    Assay Drug Dev Technol; 2013 Mar; 11(2):117-29. PubMed ID: 23116459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and dissolution enhancement strategies: current understanding and recent trends.
    Jain S; Patel N; Lin S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):875-87. PubMed ID: 25342479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid exploration of curing process design space for production of controlled-release pellets.
    Kristan K; Horvat M
    J Pharm Sci; 2012 Oct; 101(10):3924-35. PubMed ID: 22833184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model.
    Karkossa F; Krueger A; Urbaniak J; Klein S
    AAPS PharmSciTech; 2017 Feb; 18(2):309-316. PubMed ID: 27909943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations.
    Goyanes A; Hatton GB; Merchant HA; Basit AW
    Int J Pharm; 2015 Apr; 484(1-2):103-8. PubMed ID: 25721685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.
    Tan Y; Si X; Zhong L; Feng X; Yang X; Huang M; Wu C
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1669-77. PubMed ID: 27066697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling accelerated and decelerated drug release in terms of fractional release rate.
    Weiss M
    Eur J Pharm Sci; 2015 Feb; 68():51-5. PubMed ID: 25486334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches for in vitro drug release study of long acting parenteral formulations.
    Dadhaniya TM; Sharma OP; Gohel MC; Mehta PJ
    Curr Drug Deliv; 2015; 12(3):256-70. PubMed ID: 25666683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Release kinetics of single pellets and the multi-pellet system of tamsulosin hydrochloride sustained release pellets].
    Yang S; Wang CF; Li X; Li Y; Yin XZ; Guo T; Zhang JW; He J; Sun LX
    Yao Xue Xue Bao; 2014 Apr; 49(4):535-42. PubMed ID: 24974474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation.
    Govender T; Dangor CM; Chetty DJ
    J Microencapsul; 1997; 14(1):1-13. PubMed ID: 8994071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
    Willmann S; Thelen K; Lippert J
    J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New high throughput screening method for drug release measurements.
    Pelczarska A; Delie F; Domańska U; Carrupt PA; Martel S
    Eur J Pharm Biopharm; 2013 Sep; 85(1):151-7. PubMed ID: 23958326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.